Dangerous Medicines: Trasylol®

In 1993, Bayer released the drug Trasylol® (aprotinin injection).  Trasylol is an injected drug used to minimize bleeding during cardiac bypass surgery. It is estimated that approximately 4.5 million people worldwide were given this drug over the last 14 years.  However, an alarming number of recipients experienced serious side effects including strokes, heart attacks and kidney failure, some of which resulted in death.  As a result of continued pressure from international regulators, on November 5, 2007, Bayer temporarily suspended the marketing of Trasylol® until a comprehensive review of a Canadian study which showed increased risk of death can be performed.  If you or someone you know were administered Trasylol during surgery and are experiencing any side effects, contact the Law Offices of Stuart A. Kritzer, P.C. for more information.  We’re here to help.